Cargando…

Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial

We evaluated the effect of red ginseng on toxicity, health-related quality of life (HRQL) and survival after adjuvant chemotherapy in patients with epithelial ovarian cancer (EOC). A total of 30 patients with EOC were randomly assigned to placebo (n = 15) and red ginseng groups (n = 15). All patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Seung, Kim, Mi-Kyung, Lee, Maria, Kwon, Byung-Su, Suh, Dong Hoon, Song, Yong Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537886/
https://www.ncbi.nlm.nih.gov/pubmed/28753932
http://dx.doi.org/10.3390/nu9070772
_version_ 1783254268467216384
author Kim, Hee Seung
Kim, Mi-Kyung
Lee, Maria
Kwon, Byung-Su
Suh, Dong Hoon
Song, Yong Sang
author_facet Kim, Hee Seung
Kim, Mi-Kyung
Lee, Maria
Kwon, Byung-Su
Suh, Dong Hoon
Song, Yong Sang
author_sort Kim, Hee Seung
collection PubMed
description We evaluated the effect of red ginseng on toxicity, health-related quality of life (HRQL) and survival after adjuvant chemotherapy in patients with epithelial ovarian cancer (EOC). A total of 30 patients with EOC were randomly assigned to placebo (n = 15) and red ginseng groups (n = 15). All patients took placebo or red ginseng (3000 mg/day) for three months. Then, we compared changes of genotoxicity, HRQL and survival between the two groups. As a result, red ginseng reduced micronuclei yield in comparison with placebo despite no difference of binucleated cells index. Although red ginseng increased serum levels of alanine aminotransferase and aspartate aminotransferase significantly, they were within the normal value. Moreover, there were no differences in adverse events between placebo and red ginseng groups. In terms of HRQL, red ginseng was associated with improved emotional functioning and decreased symptoms of fatigue, nausea and vomiting, and dyspnea, reduced anxiety and interference affecting life and improved daytime somnolence. However, there was no effect of red ginseng on prognosis of EOC. Conclusively, red ginseng may be safe and effective to reduce genotoxicity and improve HRQL despite no benefit of survival in patients with EOC who received chemotherapy.
format Online
Article
Text
id pubmed-5537886
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-55378862017-08-04 Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial Kim, Hee Seung Kim, Mi-Kyung Lee, Maria Kwon, Byung-Su Suh, Dong Hoon Song, Yong Sang Nutrients Article We evaluated the effect of red ginseng on toxicity, health-related quality of life (HRQL) and survival after adjuvant chemotherapy in patients with epithelial ovarian cancer (EOC). A total of 30 patients with EOC were randomly assigned to placebo (n = 15) and red ginseng groups (n = 15). All patients took placebo or red ginseng (3000 mg/day) for three months. Then, we compared changes of genotoxicity, HRQL and survival between the two groups. As a result, red ginseng reduced micronuclei yield in comparison with placebo despite no difference of binucleated cells index. Although red ginseng increased serum levels of alanine aminotransferase and aspartate aminotransferase significantly, they were within the normal value. Moreover, there were no differences in adverse events between placebo and red ginseng groups. In terms of HRQL, red ginseng was associated with improved emotional functioning and decreased symptoms of fatigue, nausea and vomiting, and dyspnea, reduced anxiety and interference affecting life and improved daytime somnolence. However, there was no effect of red ginseng on prognosis of EOC. Conclusively, red ginseng may be safe and effective to reduce genotoxicity and improve HRQL despite no benefit of survival in patients with EOC who received chemotherapy. MDPI 2017-07-19 /pmc/articles/PMC5537886/ /pubmed/28753932 http://dx.doi.org/10.3390/nu9070772 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Hee Seung
Kim, Mi-Kyung
Lee, Maria
Kwon, Byung-Su
Suh, Dong Hoon
Song, Yong Sang
Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial
title Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial
title_full Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial
title_fullStr Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial
title_full_unstemmed Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial
title_short Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial
title_sort effect of red ginseng on genotoxicity and health-related quality of life after adjuvant chemotherapy in patients with epithelial ovarian cancer: a randomized, double blind, placebo-controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537886/
https://www.ncbi.nlm.nih.gov/pubmed/28753932
http://dx.doi.org/10.3390/nu9070772
work_keys_str_mv AT kimheeseung effectofredginsengongenotoxicityandhealthrelatedqualityoflifeafteradjuvantchemotherapyinpatientswithepithelialovariancancerarandomizeddoubleblindplacebocontrolledtrial
AT kimmikyung effectofredginsengongenotoxicityandhealthrelatedqualityoflifeafteradjuvantchemotherapyinpatientswithepithelialovariancancerarandomizeddoubleblindplacebocontrolledtrial
AT leemaria effectofredginsengongenotoxicityandhealthrelatedqualityoflifeafteradjuvantchemotherapyinpatientswithepithelialovariancancerarandomizeddoubleblindplacebocontrolledtrial
AT kwonbyungsu effectofredginsengongenotoxicityandhealthrelatedqualityoflifeafteradjuvantchemotherapyinpatientswithepithelialovariancancerarandomizeddoubleblindplacebocontrolledtrial
AT suhdonghoon effectofredginsengongenotoxicityandhealthrelatedqualityoflifeafteradjuvantchemotherapyinpatientswithepithelialovariancancerarandomizeddoubleblindplacebocontrolledtrial
AT songyongsang effectofredginsengongenotoxicityandhealthrelatedqualityoflifeafteradjuvantchemotherapyinpatientswithepithelialovariancancerarandomizeddoubleblindplacebocontrolledtrial